Therapy Areas: Inflammatory Diseases
ProtoKinetix AAGP Exhibits Efficacy and Safety in Model of Dry Eye Disease
8 April 2020 - - US-based clinical-stage biomedical company ProtoKinetix, Inc. (OTCQB: PKTX) having recently announced filing for patent protection for new applications of its AAGP (PKX-001) molecule,...
Polaryx Therapeutics wins FDA approval for PLX-200 IND to treat patients with juvenile neuronal ceroid lipofuscinosis
8 April 2020 - Biotech company Polaryx Therapeutics reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for Investigational New Drug Application (IND) of PLX-200...
Alnylam, Dicerna form RNAi Therapeutics Collaboration on Alpha-1 Antitrypsin Deficiency-Associated
7 April 2020 - - US-based ribonucleic acid interference therapeutics specialists Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), and Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) have form...
Vanda Pharmaceuticals to begin FDA approved clinical trial of tradipitant in hospitalized patients with COVID-19 ARDS
3 April 2020 - Biopharmaceutical company Vanda Pharmaceuticals Inc (Nasdaq:VNDA) on Thursday launched the planned ODYSSEY VLY-686-3501 clinical study for the treatment and prevention of pneumonia asso...
Arena Pharmaceuticals reveals positive top-line data from Phase one etrasimod clinical study
2 April 2020 - United States-based Arena Pharmaceuticals Inc (Nasdaq: ARNA) has revealed positive top-line data from a Phase one clinical study assessing controlled-release delivery profiles for its i...
Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected 4Q20
1 April 2020 - - Israel-based biotechnology company Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is implementing an interim analysis of the Phase III Comfort trial designed to evaluate t...
Related Headlines

InDex gets SEK2.0m grant from Sweden's Vinnova for pre-clinical development of DIMS compounds for inflammation

Lilly awarded FDA approval for Taltz to treat paediatric patients with moderate to severe plaque psoriasis

Sedana reports higher demand for AnaConDa as it may reduce inflammation and increase oxygenation in COVID-19 patients

Regeneron Pharmaceuticals and Sanofi commence Kevzara treatment of first severe COVID-19 patient

Innoplexus uses AI discovery platform to find potential combinations of prior approved drugs for COVID-19

Innoplexus reveals certain first results in artificial intelligence enabled search for COVID-19 treatment

Evolve BioSystems Inc partners with Janssen to study B. infantis EVC001 in reduction of childhood atopic dermatitis

Relief Therapeutics partners with NeuroRx to file IND for phase 2 trial of RLF-100 for COVID-19

Lumos Diagnostics Supports the Victorian Healthcare System by Providing FebriDx for a Pilot Evaluation in the Triaging of Acute Respiratory Infection Patients

Alnylam Pharmaceuticals, Gen Sign Distribution Agreement in Turkey for Onpattro 'Gene-Silencing' RNAi Therapeutic

ANI Pharmaceuticals submits prior approval supplement for Purified Cortrophin Gel in 80 U/ml to FDA

BIOLASE's Epic Hygiene Laser awarded US FDA regulatory clearance for laser bacterial reduction therapy

Cardax Releases White Paper on the Potential Role of Astaxanthin in the Treatment of Coronavirus Disease

Mylan NV restarts production of hydroxychloroquine sulfate tablets at West Virginia manufacturing facility

FDA approves Epclusa treatment for paediatric patients with any strain of Hepatitis C